Vaccine presentation and packaging advisory group: A forum for reaching consensus on vaccine product attributes

Bulletin of the World Health Organization

Volumn 91, Issue 1, 2013, Pages 75-78

  Mansoor, Osman David ^a   Kristensen, Debra ^b   Meek, Andrew ^c   Zipursky, Simona ^b   Popovaa, Olga ^d   Sharma, InderJit ^e   Miranda, Gisele ^f   Millogo, Jules ^g   Lasher, Heidi ^b  

^a UNITED NATIONS   (United States)

^b PATH   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CRUCELL HOLLAND BV   (Netherlands)

^e Serum Institute of India   (India)

^f Instituto de Technologia em Imunobiologicos   (Brazil)

^g MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; VACCINE;

DEVELOPING WORLD; VACCINE; WORLD HEALTH ORGANIZATION;

ARTICLE; COLD EXPOSURE; DRUG MANUFACTURE; DRUG PACKAGING; DRUG POTENCY; DRUG STORAGE; HEALTH CARE POLICY; HEALTH PROGRAM; IMMUNIZATION; LOWEST INCOME GROUP; PRACTICE GUIDELINE; THERMAL EXPOSURE; WORLD HEALTH ORGANIZATION;

ADVISORY COMMITTEES; CONSENSUS; DRUG LABELING; DRUG PACKAGING; UNITED STATES; VACCINES;

EID: 84871888457     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.110700     Document Type: Article

References (24)

1. Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 2007;25:3980-6. doi:10.1016/j.vaccine.2007.02.052 PMID:17382434
2. Nelson C, Froes P, Dyck AM, Chavarria J, Boda E, Coca A et al. Monitoring temperatures in the vaccine cold chain in Bolivia. Vaccine 2007;25:433-7. doi:10.1016/j.vaccine.2006.08.017 PMID:17000036
3. Setia S, Mainzer H, Washington ML, Coil G, Snyder R, Weniger BG. Frequency and causes of vaccine wastage. Vaccine 2002;20:1148-56. doi:10.1016/S0264-410X(01)00433-9 PMID:11803076
4. Techathawat S, Varinsathien P, Rasdjarmrearnsook A, Tharmaphornpilas P. Exposure to heat and freezing in the vaccine cold chain in Thailand. Vaccine 2007;25:1328-33. doi:10.1016/j.vaccine.2006.09.092 PMID:17157419
5. United States Agency for International Development. Cold chain and logistics management: an essential part of safe and effective vaccination programs. IMMUNIZATIONbasics SnapShots 2008;8:1-4. Available from: http://immunizationbasics.jsi.com/Newsletter/Archives/snapshots_volume8.pdf [accessed 1 November 2012].
6. Weir E, Hatch K. Preventing cold chain failure: vaccine storage and handling. CMAJ 2004;171:1050. doi:10.1503/cmaj.1041565 PMID:15505266
7. Landscape analysis: analysis of EVSM indicators. Ferney Voltaire: World Health Organization & PATH; 2008. Available from: http://www.path.org/publications/detail.php?i=1699 [accessed 1 November 2012].
8. Nullis-Kapp C. Health worker shortage could derail development goals. Bull World Health Organ 2005;83:5-6. PMID:15682240
9. Kuehn BM. Global shortage of health workers, brain drain stress developing countries. JAMA 2007;298:1853-5. doi:10.1001/jama.298.16.1853 PMID:17954532
10. Jodar L, Duclos P, Milstien JB, Griffiths E, Aguado MT, Clements JC. Ensuring vaccine safety in immunization programmes-a WHO perspective. Vaccine 2001;19:1594-605. doi:10.1016/S0264-410X(00)00358-3 PMID:11166881
11. Clements CJ, Larsen G, Jodar L. Technologies that make administration of vaccines safer. Vaccine 2004;22:2054-8. doi:10.1016/j.vaccine.2004.01.008 PMID:15121322
12. Kaufmann JR, Miller R, Cheyne J. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Aff (Millwood) 2011;30:1113-21. doi:10.1377/hlthaff.2011.0368 PMID:21653965
13. Vaccination: rattling the supply chain. Bull World Health Organ 2011;89:324-5. doi:10.2471/BLT.11.030511 PMID:21556298
14. Sabot O, Yadav P, Zaffran M. Maximizing every dose and dollar: the imperative of efficiency in vaccine delivery. Seattle: National Bureau of Asian Research; 2011 (Impact and Innovation Series). Available from: www.nbr.org/downloads/./CHA_MazimizingEveryDoseandDollar. pdf[accessed 1 November 2012].
15. United Nations Children's Fund, Supply Division [Internet]. Vaccine projections: quantities and pricing. New York: UNICEF; 2012. Available from: http://www.unicef.org/supply/index_7991.html [accessed 1 November 2012].
16. Developing a vision for immunization supply systems in 2020: landscape analysis summaries. Seattle: PATH & World Health Organization; 2011. Available from: http://www.path.org/publications/detail.php?i=1964 [accessed 1 November 2012].
17. Achieving the global vision for immunization supply and logistics systems: action plans. Seattle: World Health Organization & PATH; 2012. Available from: http://www.path.org/publications/detail/php.?i=2216 [accessed 1 November 2012].
18. VVPAG terms of reference and addendum. Geneva: World Health Organization; 2012. Available from: http://www.who.int/immunization_delivery/systems_policy/vppag/en/index2.html [accessed 1 November 2012].
19. Target product profile for the advance market commitment for pneumococcal conjugate vaccine. Geneva: World Health Organization; 2008. Available from: www.who.int/immunization/sage/target_product_profile.pdf [accessed 1 November 2012].
20. United Nations Children's Fund, Supply Division [Internet]. Vaccines supply overview. New York: UNICEF; 2012. Available from: http://www.unicef.org/supply/index_vaccines.html [accessed 1 November 2012].
21. Assessing the programmatic suitability of vaccine candidates for WHO prequalification. Geneva: World Health Organization; 2012 (Report No. WHO/IVB/12.10).
22. Mantel C, Wang SA. The privilege and responsibility of having choices: decision-making for new vaccines in developing countries. Health Policy Plan 2012;27:ii1-4. doi:10.1093/heapol/czs041 PMID:22513728
23. World Health Organization [Internet]. Immunization Practices Advisory Committee, 12-13 April 2013: final meeting report and recommendations. Geneva: WHO; 2012. Available from: http://www.who.int/immunization_delivery/systems_policy/IPAC_2011_April_report.pdf [accessed 1 November 2012].
24. World Health Organization [Internet]. Vaccine Presentation and Packaging Advisory Group: generic preferred product profile for vaccines, version 2.1. Geneva: WHO; 2009. Available from: http://www.who.int/entity/immunization_delivery/systems_policy/VPPAG_Generic_PPP_and_Workplan.pdf [accessed 1 November 2012].